17-7042427-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001370549.1(SLC16A11):c.683C>G(p.Ala228Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001370549.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A11 | NM_001370549.1 | c.683C>G | p.Ala228Gly | missense_variant | 4/5 | ENST00000574600.3 | NP_001357478.1 | |
SLC16A11 | NM_153357.3 | c.683C>G | p.Ala228Gly | missense_variant | 3/4 | NP_699188.2 | ||
SLC16A11 | NM_001370553.1 | c.683C>G | p.Ala228Gly | missense_variant | 4/4 | NP_001357482.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC16A11 | ENST00000574600.3 | c.683C>G | p.Ala228Gly | missense_variant | 4/5 | 3 | NM_001370549.1 | ENSP00000460927 | P1 | |
SLC16A11 | ENST00000573338.1 | n.677+503C>G | intron_variant, non_coding_transcript_variant | 1 | ||||||
SLC16A11 | ENST00000662352.3 | c.683C>G | p.Ala228Gly | missense_variant | 3/4 | ENSP00000499634 | P1 | |||
SLC16A11 | ENST00000673828.2 | c.683C>G | p.Ala228Gly | missense_variant | 4/4 | ENSP00000501313 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2021 | The c.755C>G (p.A252G) alteration is located in exon 3 (coding exon 3) of the SLC16A11 gene. This alteration results from a C to G substitution at nucleotide position 755, causing the alanine (A) at amino acid position 252 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.